Tag: specialty pharmaceutical company

January 25, 2019

Eton Pharmaceuticals Announces Licensing of Oral Liquid Product Candidate ET-104

Eton Pharmaceuticals (NASDAQ:ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that it has...
January 7, 2019

Medexus Files Business Acquisition Report

Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “Company”) (TSXV: MDP, OTCQB: PDDPF) today announced the filing of the Business Acquisition Report (“BAR”) on...
October 31, 2018

Acerus Announces Expansion of NATESTO® Agreement with medac and the Submission of NATESTO® Dossier in Europe

Acerus Pharmaceuticals Corporation (TSX:ASP) (“Acerus” or the “Company”) today announced the signing of an amendment to its existing licensing and...
October 30, 2018

Acerus Announces Executive Leadership Changes in Corporate Finance

Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP) today announced that Robert M. Motz will join the Company as Chief...
July 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top

Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...
May 9, 2018

Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update

Foamix Pharmaceuticals (NASDAQ:FOMX) a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs...
May 9, 2018

Supernus Announces First Quarter 2018 Financial Results and Record Quarterly Revenue

Supernus Pharmaceuticals (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system...